Smoking cessation therapy with varenicline

Smoking cessation therapy with varenicline

Uma M Mohanasundaram, Rajinder Chitkara, Ganesh KrishnaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, CA, USAAbstract: Smoking cessation is the only available intervention proven to halt progression of chronic obstructive pulmonary d...

Full description

Bibliographic Details
Main Authors:	Uma M Mohanasundaram, Rajinder Chitkara, Ganesh Krishna
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-06-01
Series:	International Journal of COPD
Online Access:	http://www.dovepress.com/smoking-cessation-therapy-with-varenicline-a1823

Similar Items

Smoking cessation in Asians: focus on varenicline
by: Xiao D, et al.
Published: (2015-04-01)

Predictors of treatment success in smoking cessation with varenicline combined with nicotine replacement therapy v varenicline alone
by: F Noor, et al.
Published: (2018-12-01)

Varenicline and evaluated outcomes in smoking cessation programmes
by: P. Santus, et al.
Published: (2015-11-01)

Smoking cessation in Asians: focus on varenicline [Corrigendum]
by: Xiao D, et al.
Published: (2015-07-01)

Smoking cessation: an economic analysis and review of varenicline
by: Michele A Faulkner
Published: (2009-06-01)

CHRNA4 rs1044396 is associated with smoking cessation in varenicline therapy
by: Juliana Rocha Santos, et al.
Published: (2015-02-01)

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations
by: Jon O Ebbert, et al.
Published: (2010-09-01)

Tobacco smoking cessation management: integrating varenicline in current practice
by: Laurence M Galanti
Published: (2008-08-01)

Varenicline in the management of smoking cessation: a single technology appraisal
by: D Hind, et al.
Published: (2009-09-01)

Combination of varenicline and nicotine patch for smoking cessation: A case report
by: Kelly M. Young, et al.
Published: (2019-09-01)

Efficacy and Safety of Varenicline for Smoking Cessation in Schizophrenia: A Meta-Analysis
by: Saeed Ahmed, et al.
Published: (2018-09-01)

Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation
by: S. R. Gilyarevskiy
Published: (2019-03-01)

Combination therapy of varenicline and bupropion in smoking cessation: A meta-analysis of the randomized controlled trials
by: Zhaoshuang Zhong, et al.
Published: (2019-11-01)

Combined use of varenicline and telephone-based cognitive-behavioral counselling for smoking cessation
by: O. A. Sukhovskaya, et al.
Published: (2015-12-01)

Investigating gender differences for effectiveness and side effects of varenicline during smoking cessation treatment
by: Verena Castellani, et al.

Investigating gender differences for effectiveness and side effects of varenicline during smoking cessation treatment
by: Helena Moura

Real World Study to Evaluate the Effectiveness of Varenicline and Cognitive-Behavioural Interventions for Smoking Cessation
by: Josep Mª. Ramon, et al.
Published: (2009-04-01)

Varenicline treatment for smoking cessation in high risk patients: a budget impact analysis
by: Federico Spandonaro, et al.
Published: (2017-10-01)

Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan
by: Saba Madae’en, et al.
Published: (2020-10-01)

Assessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of Varenicline.
by: Hayato Akimoto, et al.
Published: (2016-01-01)

Varenicline as a smoking cessation aid in a Greek population: a subanalysis of an observational study
by: Christina Gratziou, et al.
Published: (2012-02-01)

Preclinical pharmacology, efficacy, and safety of varenicline in smoking cessation and clinical utility in high risk patients
by: Zheng-Xiong Xi
Published: (2010-04-01)

A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
by: Baker CL, et al.
Published: (2018-01-01)

A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
by: Ali Ramazan Benli, et al.
Published: (2017-02-01)

Cost-effectiveness of retreatment with varenicline after failure with or relapse after initial treatment for smoking cessation
by: Lieven Annemans, et al.
Published: (2015-01-01)

Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink
by: Neil M Davies, et al.
Published: (2020-02-01)

Varenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherence
by: Burke MV, et al.
Published: (2016-04-01)

Extending varenicline preloading to 6 weeks facilitates smoking cessation: A single-site, randomised controlled trial
by: Abraham Bohadana, et al.
Published: (2020-02-01)

Varenicline is a smoking cessation drug that blocks alveolar expansion in mice intratracheally administrated porcine pancreatic elastase
by: Mitsuhisa Koga, et al.
Published: (2018-06-01)

Multimodal treatment for smoking cessation with varenicline in alcoholic, methadone-maintained, and psychotic patients: A one-year follow-up
by: Antonia Raich, et al.
Published: (2018-12-01)

What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
by: Joanna Leaviss, et al.
Published: (2014-05-01)

Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial.
by: Kristin V Carson-Chahhoud, et al.
Published: (2020-01-01)

Efficacy of smoking cessation with varenicline plus counselling for e-cigarettes users (VAREVAPE): A protocol for a randomized controlled trial
by: Pasquale Caponnetto, et al.
Published: (2019-09-01)

Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: preliminary findings
by: Muriah Dawn Wheelock, et al.
Published: (2014-07-01)

Cue restricted smoking increases quit rates with varenicline
by: Jaqueline R. Scholz, et al.
Published: (2021-05-01)

Safety of varenicline as an aid to smoking cessation in professional drivers and its impact on driving behaviors: An observational cohort study of taxi drivers in Beijing
by: Shuilian Chu, et al.
Published: (2020-05-01)

Varenicline: A review of the literature and place in therapy
by: Whitley HP, et al.
Published: (2007-06-01)

Effect of MDR C3435T polymorphism on Varenicline treatment in quit smoking
by: Nurgul Bozkurt, et al.

Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: a pilot study
by: Raúl H. Sansores, et al.
Published: (2016-10-01)

The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial
by: Chris Bullen, et al.
Published: (2018-05-01)